NIH-funded research NIH-funded research

Investigating how red blood cell particles affect inflammation and blood clotting in sickle cell disease

Official title: Roles of Red Blood Cell Derived Extracellular Vesicles in Complement Activation and Thromboinflammation in sickle cell disease

Funded at University of Houston · NIH-10848500 · Data updated 2026-11-12

This study is looking at tiny particles released from damaged red blood cells in people with sickle cell disease to see if they can help predict inflammation and blood clots, which are common issues for those with the condition.

More Sickle Cell Disease research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startApril 19, 2023
Project endJuly 31, 2027
Funding year2024
Award (this year)$106,486
NIH project number5K25HL159358-03
Project IDNIH-10848500 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with sickle cell disease who experience complications related to inflammation and blood clotting.

Less likely to help

Patients without a diagnosis of sickle cell disease or those who do not experience thromboinflammation may not benefit from this research.

What this research studies

This research focuses on understanding the role of extracellular vesicles released from damaged red blood cells in sickle cell disease (SCD). These vesicles may serve as biomarkers for predicting inflammation and blood clotting, which are significant complications in SCD. The study will utilize advanced microfluidic systems and functional assays to explore how these vesicles interact with the complement system, a part of the immune response, under various stress conditions. By examining these interactions, the research aims to provide insights into disease activity and potential therapeutic responses for patients with SCD.

Why it matters

Potential benefit: If successful, this research could lead to improved methods for predicting and managing complications in patients with sickle cell disease.

How similar studies have gone: While the specific approach of using extracellular vesicles in this context is relatively novel, similar studies have shown promise in understanding the mechanisms of thromboinflammation in other conditions.

Where this research is happening

  • University of Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: An, Ran — University of Houston
  • Study coordinator: An, Ran

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.